Relationship between testosterone serum levels and Slow Coronary Flow


Gül M., Tangürek B., PÜŞÜROĞLU H., Satilmisoglu H., SÜRGİT Ö., Akgül Ö., ...Daha Fazla

Turkiye Klinikleri Cardiovascular Sciences, cilt.26, sa.2, ss.79-84, 2014 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 2
  • Basım Tarihi: 2014
  • Dergi Adı: Turkiye Klinikleri Cardiovascular Sciences
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.79-84
  • Anahtar Kelimeler: Biological markers, Coronary angiography
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: Slow Coronary Flow (SCF) is a condition related to endothelial dysfunction that is considered within the spectrum of coronary artery disease (CAD). A relationship has been shown to exist between testosterone and CAD. The aim of the study is to investigate the association between the total serum testosterone level and SCF. Material and Methods: The study group consisted of 88 male subjects (mean age±55±12 SD: 1 years); 42 of the patients had SCF. The control group had 46 subjects with no significant coronary artery stenosis. Demographic characteristics were same in both groups. Coronary flow rates were determined by the TIMI frame count method. Total testosterone levels were compared between two groups. Testosterone level measurements were performed by radioimmunoassay (RIA) method. Results: Mean serum levels of total testosterone were 2.4±0.8 ng/mL in the SCF patients and 2.5±0.9 ng/mL in the control group (p=0.6). No significant association was found between the total testosterone level and TIMI frame count. The age and body mass index (BMI) averages and the frequency of diabetes, dyslipidemia and hypertension were higher in the SCF group than in controls, albeit not at a statistically significant level. Smoking habit was significantly more frequent in the SCF group. Conclusion: Even though the serum total testosterone levels seemed to be lower in the SCF patients, no statistically significant difference was found. Our findings are consistent with the known negative effects of cardiovascular risk factors on endothelial function.